The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.
Identifieur interne : 002537 ( PubMed/Corpus ); précédent : 002536; suivant : 002538The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.
Auteurs : Jacqueline Deen ; Lorenz Von Seidlein ; Francisco J. Luquero ; Christopher Troeger ; Rita Reyburn ; Anna Lena Lopez ; Amanda Debes ; David A. SackSource :
- The Lancet. Infectious diseases [ 1474-4457 ] ; 2016.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Cholera Vaccines.
- legislation & jurisprudence : Communicable Disease Control.
- organization & administration : Communicable Disease Control.
- prevention & control : Cholera.
- Administration, Oral, Emergencies, Health Policy, Humans, World Health Organization.
Abstract
Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of licensed, WHO-prequalified cholera vaccines is not sufficient to meet endemic and epidemic needs worldwide and so prioritisation is needed. We have developed a scenario approach to systematically classify situations in which oral cholera vaccination might be useful. Our scenario approach distinguishes between five types of cholera epidemiology based on experiences from around the world and provides evidence that we hope will spur the development of detailed guidelines on how and where oral cholera vaccines could, and should, be most rationally deployed.
DOI: 10.1016/S1473-3099(15)00298-4
PubMed: 26494426
Links to Exploration step
pubmed:26494426Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.</title><author><name sortKey="Deen, Jacqueline" sort="Deen, Jacqueline" uniqKey="Deen J" first="Jacqueline" last="Deen">Jacqueline Deen</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: deen.jacqueline@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Von Seidlein, Lorenz" sort="Von Seidlein, Lorenz" uniqKey="Von Seidlein L" first="Lorenz" last="Von Seidlein">Lorenz Von Seidlein</name><affiliation><nlm:affiliation>Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Luquero, Francisco J" sort="Luquero, Francisco J" uniqKey="Luquero F" first="Francisco J" last="Luquero">Francisco J. Luquero</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Epicentre, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Troeger, Christopher" sort="Troeger, Christopher" uniqKey="Troeger C" first="Christopher" last="Troeger">Christopher Troeger</name><affiliation><nlm:affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Reyburn, Rita" sort="Reyburn, Rita" uniqKey="Reyburn R" first="Rita" last="Reyburn">Rita Reyburn</name><affiliation><nlm:affiliation>Pneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Lopez, Anna Lena" sort="Lopez, Anna Lena" uniqKey="Lopez A" first="Anna Lena" last="Lopez">Anna Lena Lopez</name><affiliation><nlm:affiliation>National Institutes of Health, University of the Philippines Manila, Manila, Philippines.</nlm:affiliation></affiliation></author><author><name sortKey="Debes, Amanda" sort="Debes, Amanda" uniqKey="Debes A" first="Amanda" last="Debes">Amanda Debes</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sack, David A" sort="Sack, David A" uniqKey="Sack D" first="David A" last="Sack">David A. Sack</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26494426</idno><idno type="pmid">26494426</idno><idno type="doi">10.1016/S1473-3099(15)00298-4</idno><idno type="wicri:Area/PubMed/Corpus">002537</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002537</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.</title><author><name sortKey="Deen, Jacqueline" sort="Deen, Jacqueline" uniqKey="Deen J" first="Jacqueline" last="Deen">Jacqueline Deen</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: deen.jacqueline@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Von Seidlein, Lorenz" sort="Von Seidlein, Lorenz" uniqKey="Von Seidlein L" first="Lorenz" last="Von Seidlein">Lorenz Von Seidlein</name><affiliation><nlm:affiliation>Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.</nlm:affiliation></affiliation></author><author><name sortKey="Luquero, Francisco J" sort="Luquero, Francisco J" uniqKey="Luquero F" first="Francisco J" last="Luquero">Francisco J. Luquero</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Epicentre, Paris, France.</nlm:affiliation></affiliation></author><author><name sortKey="Troeger, Christopher" sort="Troeger, Christopher" uniqKey="Troeger C" first="Christopher" last="Troeger">Christopher Troeger</name><affiliation><nlm:affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Reyburn, Rita" sort="Reyburn, Rita" uniqKey="Reyburn R" first="Rita" last="Reyburn">Rita Reyburn</name><affiliation><nlm:affiliation>Pneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Lopez, Anna Lena" sort="Lopez, Anna Lena" uniqKey="Lopez A" first="Anna Lena" last="Lopez">Anna Lena Lopez</name><affiliation><nlm:affiliation>National Institutes of Health, University of the Philippines Manila, Manila, Philippines.</nlm:affiliation></affiliation></author><author><name sortKey="Debes, Amanda" sort="Debes, Amanda" uniqKey="Debes A" first="Amanda" last="Debes">Amanda Debes</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Sack, David A" sort="Sack, David A" uniqKey="Sack D" first="David A" last="Sack">David A. Sack</name><affiliation><nlm:affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">The Lancet. Infectious diseases</title><idno type="eISSN">1474-4457</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Cholera (prevention & control)</term><term>Cholera Vaccines (administration & dosage)</term><term>Communicable Disease Control (legislation & jurisprudence)</term><term>Communicable Disease Control (organization & administration)</term><term>Emergencies</term><term>Health Policy</term><term>Humans</term><term>World Health Organization</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cholera Vaccines</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Communicable Disease Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Cholera</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Emergencies</term><term>Health Policy</term><term>Humans</term><term>World Health Organization</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of licensed, WHO-prequalified cholera vaccines is not sufficient to meet endemic and epidemic needs worldwide and so prioritisation is needed. We have developed a scenario approach to systematically classify situations in which oral cholera vaccination might be useful. Our scenario approach distinguishes between five types of cholera epidemiology based on experiences from around the world and provides evidence that we hope will spur the development of detailed guidelines on how and where oral cholera vaccines could, and should, be most rationally deployed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26494426</PMID><DateCreated><Year>2016</Year><Month>01</Month><Day>07</Day></DateCreated><DateCompleted><Year>2016</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2017</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-4457</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Lancet. Infectious diseases</Title><ISOAbbreviation>Lancet Infect Dis</ISOAbbreviation></Journal><ArticleTitle>The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.</ArticleTitle><Pagination><MedlinePgn>125-129</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1473-3099(15)00298-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1473-3099(15)00298-4</ELocationID><Abstract><AbstractText>Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of licensed, WHO-prequalified cholera vaccines is not sufficient to meet endemic and epidemic needs worldwide and so prioritisation is needed. We have developed a scenario approach to systematically classify situations in which oral cholera vaccination might be useful. Our scenario approach distinguishes between five types of cholera epidemiology based on experiences from around the world and provides evidence that we hope will spur the development of detailed guidelines on how and where oral cholera vaccines could, and should, be most rationally deployed.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deen</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: deen.jacqueline@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Seidlein</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luquero</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Epicentre, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Troeger</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyburn</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Pneumococcal Research Group, Murdoch Children's Research Institute, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez</LastName><ForeName>Anna Lena</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>National Institutes of Health, University of the Philippines Manila, Manila, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Debes</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sack</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Delivering Oral Vaccine Effectively (DOVE), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>10</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Lancet Infect Dis</MedlineTA><NlmUniqueID>101130150</NlmUniqueID><ISSNLinking>1473-3099</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022121">Cholera Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002771" MajorTopicYN="N">Cholera</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022121" MajorTopicYN="N">Cholera Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000331" MajorTopicYN="Y">legislation & jurisprudence</QualifierName><QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006291" MajorTopicYN="Y">Health Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>01</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>08</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>08</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26494426</ArticleId><ArticleId IdType="pii">S1473-3099(15)00298-4</ArticleId><ArticleId IdType="doi">10.1016/S1473-3099(15)00298-4</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002537 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002537 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26494426
|texte= The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26494426" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |